PharmedOut, a project of Georgetown University Medical Center, exposes pharmaceutical industry marketing and foster evidence-based, cost-effective prescribing. We are the only group that critiques industry-invented and exaggerated conditions, including pseudobulbar affect (PBA), low testosterone (low-T), binge-eating disorder (BED), and gastroesophageal reflux disease (GERD). We are the only group studying industry influence on continuing medical education (CME). Originally launched for two years in 2007 by the Attorney General Consumer and Prescriber Grant Program, PharmedOut is funded primarily by individual donations.
PharmedOut Published the First Studies On:
Our Unique and Influential Peer-Reviewed Papers Describe:
PharmedOut Publishes Articles Directed to the General Public On:
PharmedOut Trains Future Leaders. We have trained over 100 medical, graduate, and undergraduate interns. PharmedOut interns – and staff – coauthor peer-reviewed publications, testify at FDA hearings, speak at national conferences, and occasionally appear on television.
Our Widely Used Online Materials Include:
The PharmedOut Newsletter. Former project manager Nicole Dubowitz Silverman launched our newsletter in 2013. Besides covering project and national news, PharmedOut Fodder focuses on underreported issues, and Andrea Sikora Newsome PharmD’s Pharmacist’s Corner provides evidence-based commentary on appropriate drug use.
The DC Center for Rational Prescribing. Together with Dr. Susan F. Wood PhD, the George Washington University Milken Institute School of Public Health and the DC Department of Health, we launched the DC Center for Rational Prescribing (DCRx), making Washington, DC the first jurisdiction in the country to provide its own evidence-based continuing education for physicians, nurses and pharmacists. More than 800 individuals have taken more than 2,000 courses. We offer two courses on opioids and three on medical cannabis, modules on generic drugs, drug approval, rational prescribing in elders, pharmaceutical marketing, taking a sexual history, and preexposure prophylaxis (PrEP). We also analyze pharmaceutical marketing expenditures in the District of Columbia and have released special reports with a focus on:
PharmedOut has published 29 papers, been mentioned in the media more than 200 times, and testified at numerous FDA hearings. We have organized and participated in many actions regarding drug safety. For example, we organized for 100 scientists and ethicists to sign a letter to the director of NIH asking that funds be allocated for research on scientific ethics and conflicts of interest. Our petition was covered in Nature, Science, The Scientist, and the Chronicle of Higher Education.
No group accomplishes more with less! Please support us.
Donate. PharmedOut welcomes gifts to support and advance its innovative educational programs and research initiatives. Our novel research and education of prescribers depend on your generous support. Credit card contributions can be made via Georgetown Giving online (choose "other" for designation and write "PharmedOut" under special designation) or by phone at (202) 687-4900. Checks should be made out to Georgetown University. Please designate PharmedOut in the memo section of your check or in accompanying correspondence and mail to the address below. All gifts are tax-deductible to the full extent specified by the law.
Invite PharmedOut Physicians to Lecture. PharmedOut physicians are available to provide Grand Rounds, residency seminars, lectures or workshops.
Alycia Hogenmiller, Project Manager, PharmedOut, firstname.lastname@example.org
Adriane Fugh-Berman, MD, Director, PharmedOut, email@example.com